A protein transduction domain located at the NH2-terminus of human translationally controlled tumor protein for delivery of active molecules to cells

Biomaterials

Volumn 32, Issue 1, 2011, Pages 222-230

  Kim, Moonhee ^a   Kim, Miyoung ^a   Kim, Hyo Young ^a   Kim, Sol ^a   Jung, Jaehoon ^a   Maeng, Jeehye ^a   Chang, Jun ^a   Lee, Kyunglim ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Adenovirus; Endocytosis; Protein transduction domain; TCTP

Indexed keywords

ACTIVE MOLECULES; ADENOVIRUS; AMINO ACID PEPTIDES; ENDOCYTOSIS; GALACTOSIDASES; IMMUNE RESPONSE; IN-CELL; IN-VITRO; LIPID RAFT; NONVIRAL; POLYCATIONS; PRE-INCUBATION; PROTEIN TRANSDUCTION DOMAIN; PROTEIN TRANSDUCTION DOMAINS; RESPIRATORY SYNCYTIAL VIRUS; TCTP;

AMINO ACIDS; ANIMALS; BIOLOGICAL MEMBRANES; CYTOLOGY; DRUG DELIVERY; GENE EXPRESSION; MOLECULAR BIOLOGY; PEPTIDES; TUMORS;

BACTERIOPHAGES;

BETA GALACTOSIDASE; CELL PENETRATING PEPTIDE; METHIONYLISOLEUCYLISOLEUCYLTYROSYLARGINYLASPARTYLLEUCYLISOLEUCYLSERYLHISTIDINE; SYNTHETIC PEPTIDE; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN 3T3; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; FEMALE; GENETIC TRANSDUCTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNIZATION; INTERNALIZATION; LIPID RAFT; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TOXICITY TESTING; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; BETA-GALACTOSIDASE; CELL LINE; DOGS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; GENE EXPRESSION; GENE PRODUCTS, TAT; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSDUCTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

ADENOVIRIDAE; ANIMALIA; MUS; RESPIRATORY SYNCYTIAL VIRUS;

EID: 78349312521     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.077     Document Type: Article

References (33)

1. Jarver P., Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 2004, 9(9):395-402.
2. Soomets U., Lindgren M., Gallet X., Hallbrink M., Elmquist A., Balaspiri L., et al. Deletion analogues of transportan. Biochim Biophys Acta 2000, 1467(1):165-176.
3. Drin G., Rousselle C., Scherrmann J.M., Rees A.R., Temsamani J. Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors. AAPS PharmSci 2002, 4(4):E26.
4. Moghimi S.M., Symonds P., Murray J.C., Hunter A.C., Debska G., Szewczyk A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 2005, 11(6):990-995.
5. Veldhoen S., Laufer S.D., Trampe A., Restle T. Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res 2006, 34(22):6561-6573.
6. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285(5433):1569-1572.
7. Chiu Y.L., Ali A., Chu C.Y., Cao H., Rana T.M. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem Biol 2004, 11(8):1165-1175.
8. Waldeck W., Pipkorn R., Korn B., Mueller G., Schick M., Toth K., et al. Transporter molecules influence the gene expression in HeLa cells. Int J Med Sci 2009, 6(1):18-27.
9. Bommer U.A., Thiele B.J. The translationally controlled tumour protein (TCTP). Int J Biochem Cell Biol 2004, 36(3):379-385.
10. Thaw P., Baxter N.J., Hounslow A.M., Price C., Waltho J.P., Craven C.J. Structure of TCTP reveals unexpected relationship with guanine nucleotide-free chaperones. Nat Struct Biol 2001, 8(8):701-704.
11. Langdon J.M., Schroeder J.T., Vonakis B.M., Bieneman A.P., Chichester K., Macdonald S.M. Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models. J Leukoc Biol 2008, 84(4):1151-1158.
12. Kim M., Min H.J., Won H.Y., Park H., Lee J.C., Park H.W., et al. Dimerization of translationally controlled tumor protein is essential for its cytokine-like activity. PLoS One 2009, 4(7):e6464.
13. MacDonald S.M., Rafnar T., Langdon J., Lichtenstein L.M. Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995, 269(5224):688-690.
14. Susini L., Besse S., Duflaut D., Lespagnol A., Beekman C., Fiucci G., et al. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ 2008, 15(8):1211-1220.
15. Liu H., Peng H.W., Cheng Y.S., Yuan H.S., Yang-Yen H.F. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 2005, 25(8):3117-3126.
16. Yang Y., Yang F., Xiong Z., Yan Y., Wang X., Nishino M., et al. An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 2005, 24(30):4778-4788.
17. Hsu Y.C., Chern J.J., Cai Y., Liu M., Choi K.W. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature 2007, 445(7129):785-788.
18. Tuynder M., Fiucci G., Prieur S., Lespagnol A., Geant A., Beaucourt S., et al. Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci U S A 2004, 101(43):15364-15369.
19. Arcuri F., Papa S., Carducci A., Romagnoli R., Liberatori S., Riparbelli M.G., et al. Translationally controlled tumor protein (TCTP) in the human prostate and prostate cancer cells: expression, distribution, and calcium binding activity. Prostate 2004, 60(2):130-140.
20. Kim M.J., Kwon J.S., Suh S.H., Suh J.K., Jung J., Lee S.N., et al. Transgenic overexpression of translationally controlled tumor protein induces systemic hypertension via repression of Na+, K+-ATPase. J Mol Cell Cardiol 2008, 44(1):151-159.
21. Richard J.P., Melikov K., Brooks H., Prevot P., Lebleu B., Chernomordik L.V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. J Biol Chem 2005, 280(15):15300-15306.
22. Argyris E.G., Kulkosky J., Meyer M.E., Xu Y., Mukhtar M., Pomerantz R.J., et al. The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity. Virology 2004, 330(2):481-486.
23. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004, 10(3):310-315.
24. Conner S.D., Schmid S.L. Regulated portals of entry into the cell. Nature 2003, 422(6927):37-44.
25. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55(6):1189-1193.
26. Green M., Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988, 55(6):1179-1188.
27. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275(5304):1320-1323.
28. Youn J.I., Park S.H., Jin H.T., Lee C.G., Seo S.H., Song M.Y., et al. Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD. Cancer Gene Ther 2008, 15(11):703-712.
29. Gratton J.P., Yu J., Griffith J.W., Babbitt R.W., Scotland R.S., Hickey R., et al. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 2003, 9(3):357-362.
30. Levine S., Klaiber-Franco R., Paradiso P.R. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 1987, 68(Pt 9):2521-2524.
31. Yu J.R., Kim S., Lee J.B., Chang J. Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection. J Virol 2008, 82(5):2350-2357.
32. Glezen W.P., Greenberg S.B., Atmar R.L., Piedra P.A., Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000, 283(4):499-505.
33. Pooga M., Hallbrink M., Zorko M., Langel U. Cell penetration by transportan. FASEB J 1998, 12(1):67-77.